在癌症治疗中以纳米技术向调节菌细胞:进展和挑战
Hongyu Yang1, Chang Peng1, Hanjie Sun1
1Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang, 110016, PR China.
Acta biomaterialia
|July 30, 2025
概括
纳米技术提供了新的策略,可以精确调节细胞菌,这是癌症治疗中至关重要的细胞过程. 这种方法提高了线粒体质量控制和瘤调节,为改进的癌症治疗铺平了道路.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 目前的癌症治疗方法临床疗效有限,需要新的治疗点.
- 线粒体,损坏的线粒体的清除,在癌症中具有显著的治疗潜力.
- 精确调节线粒仍然是癌症治疗中的一个挑战.
研究的目的:
- 提供基于纳米技术的策略的全面概述,以在癌症治疗中针对性调节线粒的策略.
- 讨论与癌症中线粒相关的机制,途径和检测方法.
- 探索使用纳米医学的前景和挑战,以调节癌症治疗中的线粒细胞衰变.
主要方法:
- 对纳米技术对线粒细胞调节的最新进展进行了回顾.
- 对基于纳米粒子的药物输送系统进行针对性癌症治疗的分析.
- 讨论独立和组合纳米粒子策略.
主要成果:
- 纳米技术使得有针对性的输送和调节线粒细胞衰变成为可能.
- 纳米粒子系统提供高准能力和深层组织透.
- 与现有疗法结合的方法显示出有前途.
结论:
- 纳米技术为癌症中精确的线粒调节提供了一个有希望的途径.
- 通过纳米医药针对性调节线粒可以提高癌症治疗的疗效.
- 需要进一步的研究来克服翻译和技术障碍.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Autophagy
4.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K


